000			02355 a2200733 4500
005			20250516074823.0
264		0	_c20130404
008			201304s 0 0 eng d
022			_a1536-4844
024	7		_a10.1002/ibd.22902 _2doi
040			_aNLM _beng _cNLM
100	1		_aKatz, Lior
245	0	0	_aDoubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. _h[electronic resource]
260			_bInflammatory bowel diseases _cNov 2012
300			_a2026-33 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aInfliximab
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aYoung Adult
700	1		_aGisbert, Javier P
700	1		_aManoogian, Beth
700	1		_aLin, Kirk
700	1		_aSteenholdt, Casper
700	1		_aMantzaris, Gerassimos J
700	1		_aAtreja, Ashish
700	1		_aRon, Yulia
700	1		_aSwaminath, Arun
700	1		_aShah, Somal
700	1		_aHart, Ailsa
700	1		_aLakatos, Peter Laszlo
700	1		_aEllul, Pierre
700	1		_aIsraeli, Eran
700	1		_aSvendsen, Mads Naundrup
700	1		_avan der Woude, C Janneke
700	1		_aKatsanos, Konstantinos H
700	1		_aYun, Laura
700	1		_aTsianos, Epameinondas V
700	1		_aNathan, Torben
700	1		_aAbreu, Maria
700	1		_aDotan, Iris
700	1		_aLashner, Bret
700	1		_aBrynskov, Jorn
700	1		_aTerdiman, Jonathan P
700	1		_aHiggins, Peter D R
700	1		_aChaparro, Maria
700	1		_aBen-Horin, Shomron
773	0		_tInflammatory bowel diseases _gvol. 18 _gno. 11 _gp. 2026-33
856	4	0	_uhttps://doi.org/10.1002/ibd.22902 _zAvailable from publisher's website
999			_c21507658 _d21507658